Amneal Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMRX and other ETFs, options, and stocks.

About AMRX

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. 

CEO
Chintu Patel
CEOChintu Patel
Employees
8,500
Employees8,500
Headquarters
Bridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded
2002
Founded2002
Employees
8,500
Employees8,500

AMRX Key Statistics

Market cap
4.09B
Market cap4.09B
Price-Earnings ratio
59.78
Price-Earnings ratio59.78
Dividend yield
Dividend yield
Average volume
1.42M
Average volume1.42M
High today
$13.85
High today$13.85
Low today
$12.79
Low today$12.79
Open price
$13.27
Open price$13.27
Volume
2.01M
Volume2.01M
52 Week high
$15.42
52 Week high$15.42
52 Week low
$7.02
52 Week low$7.02

Stock Snapshot

As of today, Amneal Pharmaceuticals(AMRX) shares are valued at $12.83. The company's market cap stands at 4.09B, with a P/E ratio of 59.78.

As of 2026-04-22, Amneal Pharmaceuticals(AMRX) stock has fluctuated between $12.79 and $13.85. The current price stands at $12.83, placing the stock +0.4% above today's low and -7.3% off the high.

The Amneal Pharmaceuticals(AMRX)'s current trading volume is 2.01M, compared to an average daily volume of 1.42M.

In the last year, Amneal Pharmaceuticals(AMRX) shares hit a 52-week high of $15.42 and a 52-week low of $7.02.

In the last year, Amneal Pharmaceuticals(AMRX) shares hit a 52-week high of $15.42 and a 52-week low of $7.02.

AMRX News

Nasdaq 8h
Amneal Pharmaceuticals Q1 Earnings and Revenues Surpass Estimates

Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to ear...

Amneal Pharmaceuticals Q1 Earnings and Revenues Surpass Estimates
TipRanks 8h
Amneal to Acquire Kashiv, Expanding Biosimilars Platform

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 9h
Amneal Pharmaceuticals to acquire Kashiv BioSciences

Amneal Pharmaceuticals (AMRX) announced that it has entered into a definitive agreement to acquire 100% of Kashiv BioSciences, in a transaction with considerati...

More AMRX News

TipRanks 2d
Amneal announces additional interim Phase 4 ELEVATE-PD study results

Amneal Pharmaceuticals (AMRX) announced new positive interim results from its ongoing Phase 4 ELEVATE-PD study, presented at the 2026 American Academy of Neurol...

Simply Wall St 4d
Does Amneal Pharmaceuticals' Inhaler Push Reveal a Durable Edge in Complex Generics?

Earlier in April 2026, Amneal Pharmaceuticals launched its first U.S. metered-dose inhalers, generic versions of PROAIR HFA and the original QVAR inhalation aer...

Does Amneal Pharmaceuticals' Inhaler Push Reveal a Durable Edge in Complex Generics?
TipRanks 5d
Amneal Pharmaceuticals initiated with a Buy at UBS

UBS analyst Ashwani Verma initiated coverage of Amneal Pharmaceuticals (AMRX) with a Buy rating and $19 price target The recent share selloff on the macro envir...

People also own

Based on the portfolios of people who own AMRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.